Ep. 156 - JPM Highlights & Alzheimer's Takeaways

from BioCentury This Week · host BioCentury

A trio of billion dollar deals for late-stage and commercial assets featuring contingent value rights were among the highlights of the first day of the J.P. Morgan Healthcare Conference in San Francisco on Monday. BioCentury's editors discuss AstraZeneca's takeout of CinCor, Ipsen's buy of Albireo and Chiesi's acquisition of Amryt as well as other takeaways from JPM, the CERSI summit and the Neuroscience Innovation Forum. The team also discusses the latest in Alzheimer's.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Jan 9, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 156 - JPM Highlights & Alzheimer's Takeaways

0:00 30:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 30 minutes long.

When was this BioCentury This Week episode published?

This episode was published on January 9, 2023.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!